Alterity Therapeutics Limited

Research Alterity Therapeutics Limited (PBN) on Bullrun: market cap EUR 70.91M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPBN
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 70.91M
• Financial periodFY2025
• Net income-EUR 12.15M
• Free cash flow-EUR 11.45M

Valuation Snapshot

latest market cap is EUR 70.91M.

About Alterity Therapeutics Limited

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage;

Frequently asked questions

What is Alterity Therapeutics Limited's market cap?

Alterity Therapeutics Limited's market capitalization is EUR 70.91M.

What does Alterity Therapeutics Limited do?

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease.